Castelli C - Search Results

1

Predictors of fractional flow reserve/instantaneous wave-free ratio discordance: impact of tailored diagnostic cut-offs on clinical outcomes of deferred lesions.

De Filippo O, Gallone G, D'Ascenzo F, Leone AM, Mancone M, Quadri G, Barbieri L, Bossi I, Boccuzzi G, Montone RA, Burzotta F, Iannaccone M, Montefusco A, Carugo S, Castelli C, Oreglia J, Cerrato E, Peirone A, Zaccardo G, Sardella G, Niccoli G, Omedè P, Varbella F, Rognoni A, Trani C, Conrotto F, Escaned J, De Ferrari GM. De Filippo O, et al. Among authors: castelli c. J Cardiovasc Med (Hagerstown). 2022 Feb 1;23(2):106-115. doi: 10.2459/JCM.0000000000001264. J Cardiovasc Med (Hagerstown). 2022. PMID: 34958314

2

Impact of extracorporeal shockwave myocardial revascularization on the ischemic burden of refractory angina patients: a single photon emission computed tomography study.

Alunni G, D'''''Amico S, Castelli C, De Lio G, Fioravanti F, Gallone G, Marra S, De Ferrari GM. Alunni G, et al. Among authors: castelli c. Minerva Cardioangiol. 2020 Dec;68(6):567-576. doi: 10.23736/S0026-4725.20.05110-5. Epub 2020 Apr 21. Minerva Cardioangiol. 2020. PMID: 32319266

3

Gas exchange response to exercise in patients with chronic heart failure.

Bellone A, Rusconi F, Frisinghelli A, Aliprandi P, Castelli C, Confalonieri M, Palange P. Bellone A, et al. Among authors: castelli c. Monaldi Arch Chest Dis. 1999 Feb;54(1):3-6. Monaldi Arch Chest Dis. 1999. PMID: 10218364

4

Multiple melanoma-associated epitopes recognized by HLA-A3-restricted CTLs and shared by melanomas but not melanocytes.

Mazzocchi A, Storkus WJ, Traversari C, Tarsini P, Maeurer MJ, Rivoltini L, Vegetti C, Belli F, Anichini A, Parmiani G, Castelli C. Mazzocchi A, et al. Among authors: castelli c. J Immunol. 1996 Oct 1;157(7):3030-8. J Immunol. 1996. PMID: 8816412

5

Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial.

Stacchiotti S, Ferrari S, Redondo A, Hindi N, Palmerini E, Vaz Salgado MA, Frezza AM, Casali PG, Gutierrez A, Lopez-Pousa A, Grignani G, Italiano A, LeCesne A, Dumont S, Blay JY, Penel N, Bernabeu D, de Alava E, Karanian M, Morosi C, Brich S, Dagrada GP, Vallacchi V, Castelli C, Brenca M, Racanelli D, Maestro R, Collini P, Cruz J, Martin-Broto J. Stacchiotti S, et al. Among authors: castelli c. Lancet Oncol. 2019 Sep;20(9):1252-1262. doi: 10.1016/S1470-2045(19)30319-5. Epub 2019 Jul 19. Lancet Oncol. 2019. PMID: 31331701 Clinical Trial.

6

Who should prescribe long-term oxygen in patients affected by chronic arterial hypoxaemia?

Bellone A, Venanzi D, De Angelis G, Adone R, Aliprandi P, Castelli C, Raineri M. Bellone A, et al. Among authors: castelli c. Monaldi Arch Chest Dis. 1994 Dec;49(5):396-8. Monaldi Arch Chest Dis. 1994. PMID: 7841975

7

Levocloperastine in the treatment of chronic nonproductive cough: comparative efficacy versus standard antitussive agents.

Aliprandi P, Castelli C, Bernorio S, Dell'Abate E, Carrara M. Aliprandi P, et al. Among authors: castelli c. Drugs Exp Clin Res. 2004;30(4):133-41. Drugs Exp Clin Res. 2004. PMID: 15553659

8

Identification of a mutated receptor-like protein tyrosine phosphatase kappa as a novel, class II HLA-restricted melanoma antigen.

Novellino L, Renkvist N, Rini F, Mazzocchi A, Rivoltini L, Greco A, Deho P, Squarcina P, Robbins PF, Parmiani G, Castelli C. Novellino L, et al. Among authors: castelli c. J Immunol. 2003 Jun 15;170(12):6363-70. doi: 10.4049/jimmunol.170.12.6363. J Immunol. 2003. PMID: 12794170

9

Human tumor-derived heat shock protein 96 mediates in vitro activation and in vivo expansion of melanoma- and colon carcinoma-specific T cells.

Rivoltini L, Castelli C, Carrabba M, Mazzaferro V, Pilla L, Huber V, Coppa J, Gallino G, Scheibenbogen C, Squarcina P, Cova A, Camerini R, Lewis JJ, Srivastava PK, Parmiani G. Rivoltini L, et al. Among authors: castelli c. J Immunol. 2003 Oct 1;171(7):3467-74. doi: 10.4049/jimmunol.171.7.3467. J Immunol. 2003. PMID: 14500642

10

Use of the V delta 1 variable region in the functional T-cell receptor alpha chain of a WT31+ cytotoxic T lymphocyte clone which specifically recognizes HLA-A2 molecule.

Castelli C, Mazzocchi A, Salvi S, Anichini A, Sensi M. Castelli C, et al. Scand J Immunol. 1992 Apr;35(4):487-94. doi: 10.1111/j.1365-3083.1992.tb02883.x. Scand J Immunol. 1992. PMID: 1313600

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

286 results

Search Page